Herve Leblanc, MD - Medicare Hospitalist in Fairlawn, OH

Herve Leblanc, MD is a medicare enrolled "Hospitalist" physician in Fairlawn, Ohio. His current practice location is 822 Kumho Dr, Fairlawn, Ohio. You can reach out to his office (for appointments etc.) via phone at (330) 576-0500.

Herve Leblanc is licensed to practice in Ohio (license number 35.093171) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1851328876.

Contact Information

Herve Leblanc, MD
822 Kumho Dr,
Fairlawn, OH 44333-9297
(330) 576-0500
Not Available



Physician's Profile

Full NameHerve Leblanc
GenderMale
SpecialityHospitalist
Location822 Kumho Dr, Fairlawn, Ohio
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1851328876
  • Provider Enumeration Date: 06/26/2006
  • Last Update Date: 01/30/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 7517979008
  • Enrollment ID: I20060627000370

Medical Identifiers

Medical identifiers for Herve Leblanc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1851328876NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist 35.093171 (Ohio)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Herve Leblanc allows following entities to bill medicare on his behalf.
Entity NameSound Inpatient Physicians-michigan Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639311996
PECOS PAC ID: 5395896849
Enrollment ID: O20090624000252

News Archive

MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases

Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes. The first targets will be rheumatoid arthritis (RA) and multiple sclerosis (MS).

Guardian interviews USAID Administrator Rajiv Shah

The Guardian examines USAID Administrator Rajiv Shah's role in U.S. development policy and looks at some of the domestic challenges he faces.

Approach used against influenza epidemics could benefit COVID-19 drug development

A new study from researchers at The University of Texas at Austin has found that some antivirals are useful for more than helping sick people get better - they also can prevent thousands of deaths and hundreds of thousands of virus cases if used in the early stages of infection.

Ionizing radiation can reduce stiffness of tumor cell microenvironment

Nearly half of all cancer patients receive radiation therapy to curb the growth of malignant cells. But little is known about how ionizing radiation affects the extracellular matrix (ECM), a patchwork of proteins and other biomolecules that surrounds cells and plays a vital role in their shape, movement and signaling functions.

Hyponatremia linked to high risk of fractures in elderly patients

A common blood disorder, hyponatremia, may be a risk factor for fractures in elderly patients, new research presented at the European Congress of Endocrinology shows.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Herve Leblanc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Herve Leblanc, MD
6190 Hospital Dr, Suite 103,
Cass City, MI 48726-1072

Ph: (989) 912-6300
Herve Leblanc, MD
822 Kumho Dr,
Fairlawn, OH 44333-9297

Ph: (330) 576-0500

News Archive

MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases

Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes. The first targets will be rheumatoid arthritis (RA) and multiple sclerosis (MS).

Guardian interviews USAID Administrator Rajiv Shah

The Guardian examines USAID Administrator Rajiv Shah's role in U.S. development policy and looks at some of the domestic challenges he faces.

Approach used against influenza epidemics could benefit COVID-19 drug development

A new study from researchers at The University of Texas at Austin has found that some antivirals are useful for more than helping sick people get better - they also can prevent thousands of deaths and hundreds of thousands of virus cases if used in the early stages of infection.

Ionizing radiation can reduce stiffness of tumor cell microenvironment

Nearly half of all cancer patients receive radiation therapy to curb the growth of malignant cells. But little is known about how ionizing radiation affects the extracellular matrix (ECM), a patchwork of proteins and other biomolecules that surrounds cells and plays a vital role in their shape, movement and signaling functions.

Hyponatremia linked to high risk of fractures in elderly patients

A common blood disorder, hyponatremia, may be a risk factor for fractures in elderly patients, new research presented at the European Congress of Endocrinology shows.

Read more News

› Verified 2 days ago


Hospitalist Doctors in Fairlawn, OH

Jennifer Jianfang Feng, M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 822 Kumho Dr, Ste 202, Fairlawn, OH 44333
Phone: 330-576-0500    Fax: 330-576-0467
Michael H Linz, MD
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 822 Kumho Dr Ste 202, Fairlawn, OH 44333
Phone: 330-576-0500    Fax: 330-576-0467
Anna Ayoub, M.D.
Hospitalist
Medicare: Medicare Enrolled
Practice Location: 822 Kumho Dr, Suite 202, Fairlawn, OH 44333
Phone: 330-576-0500    Fax: 330-576-0467
Dr. Latha M. Jayaraman, M.D.
Hospitalist
Medicare: Accepting Medicare Assignments
Practice Location: 822 Kumho Dr, Suite Number 202, Fairlawn, OH 44333
Phone: 330-576-0500    Fax: 330-576-0467

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.